Diego Ulissi fails anti-doping test from Giro d'Italia
Double Giro d'Italia stage winner's urine test was above the limit for Salbutamol
Italian Diego Ulissi failed an anti-doping test at the Giro d'Italia, where he won two stages, according to a statement from team Lampre-Merida today.
The Italian WorldTour team said that the UCI reported that he tested above the allowed limit for Salbutamol on May 21, at the end of stage 11 to Savona. The results of a urine test showed "an abnormal amount of Salbutamol (1900 ng/ml), higher than the limit allowed by the regulations, which sees the limit at 1000 ng/ml."
The 24-year-old from Tuscany won two uphill stages, the fifth one to Viggiano and the eighth one to Montecopiolo. He abandoned after stage 17 to Vittorio Veneto after taking antibiotics to fight a sore throat and temperature.
"It is important to point out that Diego Ulissi, accompanied by Dr Carlo Guardascione (head team doctor) had declared in his statement taken prior to the anti-doping control, the assumption before the race of Ventolin (2 puffs, equivalent to 100 ng of Salbutamol each) and paracetamol during the race, the latter given by the race doctor due to the crash which occurred during the stage in which he had been involved with many other athletes," Lampre said in its statement.
"The athlete himself and the medical staff of the team will continue to explore the reasons why the urine has been identified as having an abnormal and high presence of Salbutamol, compared to only two inhalations performed."
Lampre provisionally suspended Ulissi according to anti-doping rules and reported that Ulissi wants to undergo tests to help explain the reading.
Many riders in the peloton use inhalers with Salbutamol to treat asthma. The issue came to light during the Critérium du Dauphiné two weeks ago when television cameras showed Chris Froome puffing on an inhaler prior to winning the Col du Béal stage.
Get The Leadout Newsletter
The latest race content, interviews, features, reviews and expert buying guides, direct to your inbox!
According to UCI rules, therapeutic use exemption (TUE) is only needed to treat asthma only if an athlete is using over a certain amount. You do not need an exemption for Salmeterol, Salbutamol (up to a daily dose of 1600 micrograms) and/or Formoterol (up to a daily dose of 54 micrograms). Terbutaline requires an exception.
Some inhaler cases brought bans. Alessandro Petacchi served a ban after testers found excess levels of Salbutamol in his body. He said that he accidentally took too many sprays in the day. Igor González de Galdeano and Matteo Trentin also served bans.
Sky and UCI under scrutiny for Chris Froome's steroid TUE
Calls made to tighten up the Union Cycliste Internationale's procedure for administering Therapeutic Use Exemption certificates
Chris Froome and Sky respond to inhaler video
Sky's leader was filmed puffing on an asthma inhaler during stage two of the Criterium du Dauphine
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Gregor Brown is an experienced cycling journalist, based in Florence, Italy. He has covered races all over the world for over a decade - following the Giro, Tour de France, and every major race since 2006. His love of cycling began with freestyle and BMX, before the 1998 Tour de France led him to a deep appreciation of the road racing season.
-
USA Cycling unveils 2025 National Championship schedule with 17 chances to claim the Stars and Stripes jersey
From cycling eSports in February to cyclocross in December, here are the dates and locations for the 2025 season
By Anne-Marije Rook Published
-
Tech of the week: A shockingly expensive steel bike from Colnago, a surprisingly affordable carbon bike from Pinarello, DT Swiss energises our cycling lives and Pog's bars are now yours to buy
Colnago's Steelnova is a thing of beauty but you'll pay for the pleasure, while Pinarello's F1 is an inexpensive gateway to the brand. DT Swiss enters the dynamo hub market and Enve brings Pog's cockpit to market
By Luke Friend Published
-
Is this the £17,000 bike that will carry Tadej Pogačar to the rainbow jersey?
Colnago launch special edition V4RS Tadej ahead of the elite men’s road race at the World Championships
By Tom Thewlis Published
-
Spotted: Tadej Pogačar running prototype Enve TT bars, which have seen UAE net time trial podiums all season
A development project, the extensions are not yet commercially available, but Enve says it’s ‘excited by the results and believe the initial goals have been achieved’
By Anne-Marije Rook Published
-
'There are serious implications' - Tadej Pogačar's UAE Team Emirates face sanctions threat
Growing pressure on Western governments to sanction UAE over Russia could spell trouble for Tadej Pogačar's team
By Chris Marshall-Bell Published
-
UAE Emirates rider Alexys Brunel retires from professional cycling at 23
The young French rider is leaving the sport to focus on other challenges in life
By Ryan Dabbs Published
-
Tadej Pogačar returns to training after contracting covid
UAE Team Emirates say that Slovenian is still on track to make season debut at UAE Tour
By Adam Becket Published
-
Matteo Trentin: Roads are 'more of a jungle than a proper training environment'
Italian says that more needs to be done for cycling safety to protect the future of the sport
By Adam Becket Published
-
What did we learn from the first elite road races of the year?
Alejandro Valverde is still good; Lotto-Soudal are hungry for results; Biniam Girmay might be a force to be reckoned with
By Adam Becket Published
-
Brandon McNulty wins Trofeo Calvia, the first elite men's race of 2022
UAE-Emirates American rider wins the first part of the Challenge Mallorca with 60km solo attack
By Adam Becket Published